A closer look at the **Japan FSP Market segment** reveals that **Clinical Monitoring** continues to hold a position of primary importance, often contributing largest share of service revenue. This segment’s dominance is driven by its essential role in ensuring the integrity, compliance, and patient safety of every clinical trial cthe onducted in Japan. Given the PMDA's rigorous quality...